Fig. 1From: Homologous recombination deficiency status predicts response to platinum-based chemotherapy in Chinese patients with high-grade serous ovarian carcinomaDistribution of deleterious mutations detected in BRCA1 and BRCA2 genes. Sticks represent mutation positions. The number represents the number of samples with the mutation (the unmarked represents 1). The colors of the bar represent the functional domains of BRCABack to article page